In the latest trading session, UnitedHealth Group (UNH) closed at $503.80, marking a +0.96% move from the previous day.
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, with both citing increased threats after a UnitedHealth insurance executive was murdered outside the company's investor meeting in December, regulatory filings show.
@ProsperTradingAcademy's Scott Bauer turns to three stocks he thinks are hitting critical price action in their charts. He analyzes the latest moves in Goldman Sachs (GS), ServiceNow (NOW) and UnitedHealth Group (UNH).
UnitedHealth, SAP, Toyota and Better Choice are included in this Analyst Blog.
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud case accusing UnitedHealth Group of keeping overpayments from the government for patients on its Medicare insurance plans.
UnitedHealth Group Inc ticked up on Tuesday after winning a favourable finding in a long-running case against the Department of Justice over alleged Medicare fraud. A special master overseeing collection of evidence recommended rejecting the case, in which UnitedHealth is claimed to have overbilled Medicare by at least $2.1 billion.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
U.S. Senator Chuck Grassley has sent a letter to UnitedHealth CEO Andrew Witty on Monday demanding detailed information on the company's Medicare billing practices, the Wall Street Journal reported.
UnitedHealth Group (UNH) closed at $461.52 in the latest trading session, marking a -1.05% move from the prior day.
Few stocks get this oversold this quickly, especially mega-cap names like UnitedHealth Group Inc. NYSE: UNH. After a 45% rally from March into December, the stock has now collapsed 30%, sending it back to multi-year lows.
UnitedHealth Group faces unconfirmed allegations of inflating risk ratings for reimbursements, causing market panic despite no DOJ confirmation or filed charges. UNH's diversified business model and robust forward guidance suggest the market has likely overreacted to these headwinds. UNH's valuation is arguably undervalued now, while its price action suggests a strong support zone is in place for dip buyers.